secwatch.observer — SEC 8-K summary
======================================

Issuer:     MeiraGTx Holdings plc (MGTX)
CIK:        0001735438
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001558370-23-019944
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 1.02, 2.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MeiraGTx sells bota-vec rights to J&J's Janssen for up to $415M; $130M upfront/near-term
--------------------------------------------------------------------------------

- Upfront $65M at signing; additional $50M expected Q1 2024 and $15M later, totaling $130M near-term.
- Up to $285M in milestones tied to first U.S./EU commercial sales and manufacturing tech transfer.
- MeiraGTx enters commercial supply agreement with Janssen for bota-vec manufacturing.
- Cash runway extended to mid-2026, including $30M Sanofi investment from October 2023.
- Prior Collaboration, Option and License Agreement with Janssen terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1735438/000155837023019944/0001558370-23-019944-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1735438/000155837023019944/mgtx-20231220x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019944

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer